← Evidence map

ArticleCancer chemotherapy and pharmacology2026

Why are we still using cisplatin? : Rationale for the continued use of cisplatin in oncology.

Jemma Arakelyan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41954763